#atm .Worth a listen. Q&A with Mark Thompson, The King of Tin via @YouTube.

#csfs.Named changed then. Trading update tomorrow…?.

#AVCT.AVA6000 will surely completely replace doxorubicin? .Very interesting that TME:plasma concentration 10-100:1 irrespective of FAP tumour expression. Amazing results. Let’s hope for significant LDs to improve the share price before we have the IP literally stolen from us!.

#AVCT .Exquisite delivery of the payload to the tumour microenvironment.

#AVCT.So we'll find out how C7 patients are getting on in April at the AACR. A tiny cohort of patients but screened for high FAP expression and being treated at an earlier stage. Very important results short term for AVCT. 🤞.

#AVCT.Accumulating more as I can. My biggest fear contrary to what many seem to want is a TO at this point. I’d much rather a placing if needed even at this embarrassing SP!.Again I’d advise any serious investor to read ‘For Blood and Money’. AIM is a pile of turd….!.

#AVCT .Can't not buy more at £1. Nuts!.

#AVCT .Good Q&A. No direct answer to how we are screening the patients for 1a/2. Possibly related to the IP that needs protecting? .This is very relevant for how AVA6000 will be used in everyday practice.

#AVCT.Does anyone know how we are FAP screening for 1B and 2? FAPi PET is someway off for widespread use.

#AVCT.Completely extraordinary!.Appreciate everyone has there own investing/trading style but selling shares today!!!!? .Nuts!.

So #AVCT 1a results rns tomorrow prior to the presentation. Genuinely believe tomorrow will be a seminal moment in oncology. Will it be accompanied by the inevitable first licensing rns. ? .Odds against but BP will have been in the data room.

RT @OndoPlc: @stockbox interviewed Craig and the team live from Las Vegas from the conference floor! Click to watch #ONDO.

#AVCT. Great interview from AS with PH. Apart from putting some colour in the rns incredible clinical comments. No rush to raise capital. Will be non-dilutive. Many options available.

Fantastic update #avct!.Most of the previous cohort patients had cancer not usually treated with doxorubicin so great news for them and for so many patients in the future.

#avct for a £1! Didn’t think I’d see it again. Bought more. I’ve seen nothing to dissuade me this will be a multi billion pound company. Looking forward to the AGM.